QA: GLYCOMIMETICS INC in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001253689_2023_GLYCOMIMETICS_INC.pdf

Logs

info NetIncome node detected by revenue/expenses heuristic input.sec.calculation_linkbase.edgar_model_mapping {'net_inc_node': 'OperatingIncomeLoss'}

Graph

Absolute values for 0001253689, GLYCOMIMETICS INC

  xvar xval
0 AssetsCurrent 50,714,705
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 242,390
3 remainder_Assets 853,494
4 LiabilitiesCurrent 8,880,752
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 19,087,443
9 ResearchAndDevelopmentExpense 28,390,879
10 remainder_Expenses 0
11 remainder_Revenues 75,000
12 remainder_NetIncome 0
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 51,810,589
1 Liabilities 8,880,752
2 Expenses 47,478,322
3 Revenues 75,000
4 StockholdersEquity 42,929,837
5 NetIncome -47,403,322
6 ComprehensiveNetIncome -47,403,322
7 BaseVar 54,122,332
8 EconomicCapitalRatio 0.871

Edgar->Model Mapping

Feature Distribution

Change over Time